Edrophonium-atropine composition and therapeutic uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 28, 1990
Issued Date -
N/A
app pub date -
Oct 18, 1988
filing date -
Aug 27, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A composition is provided which includes a balanced combination of an edrophonium component and an atropine component. A preferred embodiment has 0.5 mg of edrophonium chloride and 8 micrograms of atropine sulfate, with respect to patient weight. The inventive composition is useful to antagonize nondepolarizing blockade during medical treatment when muscle relaxation is no longer necessary, provides extremely rapid onset of action and results in minimal heart rate changes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully